Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Partial Meniscal Replacement with Spongioflex® — Stella

Home/Partial Meniscal Loss/Partial Meniscal Replacement with Spongioflex®

View on ClinicalTrials.gov

Recruiting

Back to Partial Meniscal Loss trials

Partial Meniscal Replacement with Spongioflex®

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Germany

Maria-Josef-Hospital Greven GmbH, Greven, North Rhine-Westphalia

Key details

Phase

Post-approval study

Sponsor

Maria-Josef-Hospital Greven

Enrollment target

~40 participants

Started

November 2024

Primary completion

November 2029

Age range

18 Years – 60 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.